News
WEBINAR | Will the approval of one or more AD drug unleash the use of amyloid PET imaging?
Listen the webinar on demand and be part of the forefront of PET imaging in Alzheimer's disease This interesting webinar […]
See more
Successful rigging of IBA's Cyclone® 30XP at POLATOM, Poland
We are happy to announce the successful rigging of our Cyclone® 30XP cyclotron at POLATOM that marks a significant milestone […]
See more
IBA, CMI and Life Molecular Imaging announce Japanese approval for the reimbursement of amyloid-PET diagnostic Neuraceq® in Alzheimer's disease
Wednesday, December 13rd, 2023 Louvain-la-Neuve, Belgium, December 13, 2023 – IBA (Ion Beam Applications S.A., EURONEXT), CMI Inc. and Life […]
See moreIBA pioneers theranostic advancements, empowering the market to produce Astatine-211
Tuesday, December 12th, 2023 Rigging of the Cyclone® 30XP in Poland completed with a further two sites in Germany and […]
See more
Successful rigging of IBA's Cyclone Kiube at SIAT, China
Celebrating a significant achievement with the successful rigging of IBA's Cyclone® Kiube at Shenzen Institute of Advanced Technology, Chinese Academy […]
See more
Register for the learn & Talk session at SNMMI
Discover IBA's Learn and Talk sessions at SNMMI: Advantages and Disadvantages of 225Ac-PSMA therapy in Prostate Cancer Patients Prof. Sathkege […]
See more
IBA Launches AKURACY®, an Integrated Solution for Cardiac PET Imaging at EACVI Meeting in Barcelona
The IBA Akuracy® is an innovative user-friendly solution designed for the automated production of 13N-ammonia used for cardiac imaging. Louvain-la-Neuve, […]
See more
Have you already seen a flying Cyclotron?
We are proud to announce that a new Cyclone® KIUBE was rigged in Pretoria, South Africa, at Steve Biko Academic […]
See more
IBA Reports Full Year 2022 Results
ALL-TIME RECORD ORDER INTAKE AND BACKLOG IBA ANNOUNCES MID-TERM GUIDANCE Louvain-la-Neuve, Belgium, 23 March 2023 - IBA (Ion Beam Applications […]
See more